Antibody Drug Conjugates Market to Reach USD 24.26 Billion by 2031 | Straits Research | #antibody drug conjugates market # ADC market growth # targeted cancer therapy # monoclonal antibodies # cleavable linker technology # non-cleavable linker # blood cancer treatment # breast cancer therapy # urothelial cancer drugs # pharmaceutical innovations

Other

Antibody Drug Conjugates Market to Reach USD 24.26 Billion by 2031 | Straits Research

According to Straits Research, the global antibody drug conjugates (ADC) market size was valued at $6.48 billion in 2022. It is projected to reach $24.26 billion by 2031, growing at a CAGR of 15.8% during the forecast period (2023–2031).